Page last updated: 2024-11-07

9-methyl-7-bromoeudistomin d

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-methyl-7-bromoeudistomin D: potent inducer of calcium release from sarcoplasmic reticulum of skeletal muscle [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID129958
CHEBI ID34514
SCHEMBL ID7083487
MeSH IDM0168619

Synonyms (16)

Synonym
C13748 ,
9-methyl-7-bromoeudistomin d
mbed
123363-40-6
5,7-dibromo-9-methylpyrido[3,4-b]indol-6-ol
AC1L2WIW ,
9h-pyrido(3,4-b)indol-6-ol, 5,7-dibromo-9-methyl-
9-methyl-7-bromoeudistomin-d
CHEBI:34514
SCHEMBL7083487
5,7-dibromo-9-methyl-pyrido[3,4-b]indol-6-ol
surecn7083487
DTXSID10153990
AKOS028111022
9h-pyrido[3,4-b]indol-6-ol, 5,7-dibromo-9-methyl-
Q27116124

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationship of caffeine-induced inhibition of cAMP-PDEs was not correlated with the stimulation of insulin secretion."( Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion.
Ahmed, M; Bruton, JD; Frame, M; Furman, BL; Islam, MS; Lemmens, R; Persson-Sjögren, S; Pyne, NJ; Shi, CL; Westerblad, H, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
beta-carbolinesAny pyridoindole containing a beta-carboline skeleton and their hydrogenated derivatives
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's11 (73.33)18.2507
2000's2 (13.33)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]